NO995908L - Implantater for kontrollert frigivning av farmasoeytisk aktive bestanddeler samt fremgangsmåte for fremstilling derav - Google Patents

Implantater for kontrollert frigivning av farmasoeytisk aktive bestanddeler samt fremgangsmåte for fremstilling derav

Info

Publication number
NO995908L
NO995908L NO995908A NO995908A NO995908L NO 995908 L NO995908 L NO 995908L NO 995908 A NO995908 A NO 995908A NO 995908 A NO995908 A NO 995908A NO 995908 L NO995908 L NO 995908L
Authority
NO
Norway
Prior art keywords
preparation
controlled release
pharmaceutically active
implants
core
Prior art date
Application number
NO995908A
Other languages
English (en)
Norwegian (no)
Other versions
NO995908D0 (no
Inventor
Alexandra Rothen-Weinhold
Robert Gurny
Piero Orsolini
Frederic Heimgartner
Original Assignee
Debio Rech Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Debio Rech Pharma Sa filed Critical Debio Rech Pharma Sa
Publication of NO995908D0 publication Critical patent/NO995908D0/no
Publication of NO995908L publication Critical patent/NO995908L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0092—Hollow drug-filled fibres, tubes of the core-shell type, coated fibres, coated rods, microtubules or nanotubes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Nanotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO995908A 1997-06-04 1999-12-02 Implantater for kontrollert frigivning av farmasoeytisk aktive bestanddeler samt fremgangsmåte for fremstilling derav NO995908L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9706874 1997-06-04
PCT/EP1998/003270 WO1998055101A1 (fr) 1997-06-04 1998-06-02 Implants pour la liberation controlee de principes pharmaceutiquement actifs et procede pour leur fabrication

Publications (2)

Publication Number Publication Date
NO995908D0 NO995908D0 (no) 1999-12-02
NO995908L true NO995908L (no) 1999-12-02

Family

ID=9507573

Family Applications (1)

Application Number Title Priority Date Filing Date
NO995908A NO995908L (no) 1997-06-04 1999-12-02 Implantater for kontrollert frigivning av farmasoeytisk aktive bestanddeler samt fremgangsmåte for fremstilling derav

Country Status (10)

Country Link
US (1) US6319512B1 (de)
EP (1) EP1001743B1 (de)
JP (1) JP2002511075A (de)
AT (1) ATE316779T1 (de)
AU (1) AU742372B2 (de)
CA (1) CA2291659A1 (de)
DE (1) DE69833375D1 (de)
IL (1) IL133105A (de)
NO (1) NO995908L (de)
WO (1) WO1998055101A1 (de)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6767550B1 (en) * 2000-06-30 2004-07-27 Berkeley Advanced Biomaterials, Inc. Hydroxyapatite based drug delivery implant for cancer treatment
AU2001296770A1 (en) * 2000-10-06 2002-04-15 Durect Corporation Devices and methods for management of inflammation
US7666445B2 (en) * 2000-10-20 2010-02-23 The Trustees Of The University Of Pennsylvania Polymer-based surgically implantable haloperidol delivery systems and methods for their production and use
WO2003000156A1 (en) 2001-06-22 2003-01-03 Southern Biosystems, Inc. Zero-order prolonged release coaxial implants
AU2002313517B2 (en) * 2001-08-31 2007-09-06 Bayer Schering Pharma Oy Drug delivery system
DE10237572A1 (de) 2002-08-13 2004-02-26 Biotronik Meß- und Therapiegeräte GmbH & Co. Ingenieurbüro Berlin Stent mit polymerer Beschichtung
SE0202619D0 (sv) * 2002-09-05 2002-09-05 Fredrik Nederberg New Polymers and Applications
US8221778B2 (en) 2005-01-12 2012-07-17 The Trustees Of The University Of Pennsylvania Drug-containing implants and methods of use thereof
US8329203B2 (en) * 2004-01-12 2012-12-11 The Trustees Of The University Of Pennsylvania Drug-containing implants and methods of use thereof
CA2553254C (en) * 2004-01-12 2013-12-17 The Trustees Of The University Of Pennsylvania Long-term delivery formulations and methods of use thereof
AU2006269927B2 (en) * 2004-01-12 2013-05-16 The Trustees Of The University Of Pennsylvania Drug-containing implants and methods of use thereof
US8119154B2 (en) * 2004-04-30 2012-02-21 Allergan, Inc. Sustained release intraocular implants and related methods
WO2005107715A1 (en) * 2004-05-11 2005-11-17 Debio Recherche Pharmaceutique S.A. Implantable composition
WO2006078320A2 (en) 2004-08-04 2006-07-27 Brookwood Pharmaceuticals, Inc. Methods for manufacturing delivery devices and devices thereof
ES2755032T3 (es) * 2005-12-22 2020-04-21 Novartis Ag Formulación de liberación sostenida que comprende octreótido y dos o más polímeros de poliláctido-co-glicólido
PT2010184E (pt) * 2006-04-06 2013-04-03 Nupathe Inc Implantes para o tratamento dos estados associados à dopamina
BRPI0711048A2 (pt) * 2006-05-09 2011-08-23 Astrazeneca Ab formulações parenteral esterilizada e sólida estáveis, solução para administração parenteral, processos para a preparação de uma formulação e para a fabricação de um produto, método para prevenir ou tratar doenças gastrintestinais, uso de uma formulação sólida estável
ITMI20061538A1 (it) * 2006-08-02 2008-02-03 Mediolanum Pharmaceuticals Ltd Impianti sottocutanei in grado di rilasciare il principio attivo per un periodo prolungato di tempo
WO2009085952A1 (en) 2007-12-20 2009-07-09 Brookwood Pharmaceuticals, Inc. Process for preparing microparticles having a low residual solvent volume
WO2010088682A2 (en) * 2009-02-02 2010-08-05 Medtronic, Inc. Composite antimicrobial accessory including a membrane layer and a porous layer
EP2246063A1 (de) 2009-04-29 2010-11-03 Ipsen Pharma S.A.S. GnRH Analoge enthaltende Retardformulierungen
US8858983B2 (en) * 2009-04-30 2014-10-14 Medtronic, Inc. Antioxidants and antimicrobial accessories including antioxidants
BR112012002341A8 (pt) 2009-08-06 2017-10-10 Koninklijke Philips Electronics Nv Semente radioativa para uso na terapia oncológica e método de terapia oncológica
JP2013505251A (ja) * 2009-09-17 2013-02-14 エボニック デグサ コーポレイション 放出プロファイルが異なるインプラントデバイス並びにその製造及び使用方法
US8911427B2 (en) 2010-12-28 2014-12-16 Medtronic, Inc. Therapeutic agent reservoir delivery system
US12403291B2 (en) 2019-08-30 2025-09-02 Intersect Ent, Inc. Submucosal bioresorbable drug eluting platform

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2041377B (en) * 1979-01-22 1983-09-28 Woodroof Lab Inc Bio compatible and blood compatible materials and methods
US5011692A (en) * 1985-12-28 1991-04-30 Sumitomo Pharmaceuticals Company, Limited Sustained pulsewise release pharmaceutical preparation
US4894231A (en) 1987-07-28 1990-01-16 Biomeasure, Inc. Therapeutic agent delivery system
GB2209937B (en) * 1987-09-21 1991-07-03 Depiopharm S A Water insoluble polypeptides
JPH05503934A (ja) 1990-01-30 1993-06-24 アクゾ・エヌ・ヴエー 壁により完全に包囲され、１種以上の活性物質で全部又は一部を充填した中空空間から成る、活性物質の調節送達のための物品
US5378475A (en) * 1991-02-21 1995-01-03 University Of Kentucky Research Foundation Sustained release drug delivery devices
ZA935569B (en) * 1992-07-31 1994-04-12 Daratech Pty Ltd Controlled release implants
JP3720386B2 (ja) * 1993-12-27 2005-11-24 住友製薬株式会社 薬物放出制御製剤
AUPM897594A0 (en) * 1994-10-25 1994-11-17 Daratech Pty Ltd Controlled release container
NZ331186A (en) * 1996-02-02 2000-04-28 Alza Corp Osmotically driven sustained delivery drug delivery capsule

Also Published As

Publication number Publication date
JP2002511075A (ja) 2002-04-09
CA2291659A1 (fr) 1998-12-10
US6319512B1 (en) 2001-11-20
EP1001743A1 (de) 2000-05-24
AU8109398A (en) 1998-12-21
IL133105A0 (en) 2001-03-19
WO1998055101A1 (fr) 1998-12-10
NO995908D0 (no) 1999-12-02
AU742372B2 (en) 2002-01-03
DE69833375D1 (de) 2006-04-13
IL133105A (en) 2004-09-27
EP1001743B1 (de) 2006-02-01
ATE316779T1 (de) 2006-02-15

Similar Documents

Publication Publication Date Title
NO995908D0 (no) Implantater for kontrollert frigivning av farmasöytisk aktive bestanddeler samt fremgangsmåte for fremstilling derav
PT90153A (pt) Processo para a preparacao de composicoes farmaceuticas de libertacao controlada
GEP20022833B (en) New Controlled Release Bead, Method of Producing the Same and Multiple Unit Formulation Comprising It
CA2158638A1 (en) A Composition and a Method for Tissue Augmentation
NO964939L (no) Fremgangsmåte for fremstilling av virkestoffpreparater i form av en fast lösning av virkestoffet i en polymermatriks, samt virkestoffpreparater fremstilt ved hjelp av denne fremgangsmåte
NO952131L (no) Fremgangsmåte for behandling av et kirurgisk metallimplantat
HUT50624A (en) Process for producing pharmaceuical compositions with controlled release of active ingredient
WO2000037056A3 (en) Composition and method for treating glaucoma
HUT56267A (en) Process for producing pharmaceutical compositions having controlled release of active ingredient
AU1025199A (en) Coated medical implants, method for producing them, and use of the same for preventing restenosis
EP0761239A4 (de) Desodorierendes verfahren, deodorant, verfahren zur deodorantherstellung und desodorierende ausstattung
HUP9600116A3 (en) Fungicidal composition containing benzophenone, process for preparation of the active ingredients and method for the control of fungi.
EP0923955A3 (de) Verfahren zur Herstellung eines künstliches Organs, Hohlfasermembran, und Hohlfaserdialysator
NO995843D0 (no) Farmasöytisk preparat omfattende vWF-propeptid
WO1997003188A3 (de) Verwendung von mp52 oder mp121 zur behandlung und prävention von erkrankungen des nervensystems
NZ503372A (en) Chemical supplementation of bone by exposing bone to a therapeutic compound and applying a potential difference across the bone or tissue
PL312491A1 (en) Novel benzoguanidine derivatives, method of obtaining them, their application for producing pharmaceutical agents, method of treating arrhytmia and pharmaceutical agent as such
FR2845289B1 (fr) Spheroides, procede de preparation et compositions pharmaceutiques.
GEP19991819B (en) Method for Production of Therapeutic Form of Carbamazepin with Retarded Active Substance Release
AU8166191A (en) Method for treatment of bone wasting diseases
AP9801416A0 (en) Method Of treating a plant disease.
DK0830106T3 (da) Vævsladesystem til implanterbare biologiske indretninger
GR3035533T3 (en) Active substance controlled release devices and process for producing the same
PL324181A1 (en) Substituted hydrasine phenylsulphonyl ireas, method of obtaining them and their application as herbicides and plant growth controlling agents
FR2736548B1 (fr) Utilisation d'un retinoide pour la preparation d'un medicament antibacterien et methode de traitement cosmetique

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application